153 related articles for article (PubMed ID: 3620708)
21. Prognostic significance of lymphocyte morphology in patients with advanced chronic lymphocytic leukemia treated with first line therapy of fludarabine + prednisone.
Mauro FR; Gentile M; Mancini F; Giannarelli D; Guarini A; De Propriis MS; Cerretti R; Foa R
Haematologica; 2002 Jun; 87(6):602-8. PubMed ID: 12031916
[TBL] [Abstract][Full Text] [Related]
22. A review of the prognostic role of cytogenetic, phenotypic, morphologic, and immune function characteristics in chronic lymphocytic leukemia.
Rai KR; Sawitsky A
Blood Cells; 1987; 12(2):327-38. PubMed ID: 3304471
[TBL] [Abstract][Full Text] [Related]
23. [Prognosis of chronic lymphatic leukemia. Retrospective study of the survival period 47 patients].
Scolozzi R; Boccafogli A; Romanini D; Ramazzina E; Careri C; Guidoboni CA
Minerva Med; 1981 Feb; 72(4-5):205-11. PubMed ID: 7207844
[TBL] [Abstract][Full Text] [Related]
24. Clinico-prognostic implications of increased levels of soluble CD54 in the serum of B-cell chronic lymphocytic leukemia patients. Results of a multivariate survival analysis.
Molica S; Levato D; Dell' Olio M; Cascavilla N; Matera R; Minervini M; Dattilo A; Carotenuto M; Musto P
Haematologica; 1997; 82(2):148-51. PubMed ID: 9175316
[TBL] [Abstract][Full Text] [Related]
25. Clinical and prognostic evaluation of bone marrow infiltration (biopsy versus aspirate) in early chronic lymphocytic leukemia. A single center study.
Molica S; Tucci L; Levato D; Docimo C
Haematologica; 1997; 82(3):286-90. PubMed ID: 9234573
[TBL] [Abstract][Full Text] [Related]
26. CD38 expression in B-chronic lymphocytic leukemia: association with clinical presentation and outcome in 155 patients.
Domingo-Domènech E; Domingo-Clarós A; Gonzàlez-Barca E; Beneitez D; Alonso E; Romagosa V; De Sanjos S; Petit J; Grañena A; Fernández de Sevilla A
Haematologica; 2002 Oct; 87(10):1021-7. PubMed ID: 12368155
[TBL] [Abstract][Full Text] [Related]
27. [Comparative study of the peripheral lymphocyte count in controls and in patients with chronic lymphocytic leukemias 4 hours after injection of hydrocortisone (author's transl)].
Dighiero G; Charron D; Vaugier G; Leporrier M; Debré P; d'Athis P; Binet JL
Nouv Rev Fr Hematol (1978); 1978 Jun; 20(2):317-22. PubMed ID: 309108
[TBL] [Abstract][Full Text] [Related]
28. Possible prognostic significance of the assessment of dipeptidylpeptidase II in peripheral blood lymphocytes of patients with chronic lymphocytic leukemia.
Klener P; Lojda Z; Háber J; Kvasnicka J
Neoplasma; 1987; 34(5):581-6. PubMed ID: 3696300
[TBL] [Abstract][Full Text] [Related]
29. [Leukocyte doubling time as a prognostic factor in chronic lymphocytic leukemia].
Koberda J; Czyz J; Hellmann A
Acta Haematol Pol; 1989; 20(2):195-200. PubMed ID: 2638538
[TBL] [Abstract][Full Text] [Related]
30. [Prognostic value of peripheral blood T-lymphocyte count in lymphocytic leukemia].
Płuzańska A; Gawor E; Robak T; Polkowska-Kulesza E; Krykowski E; Dmochowska M; Kuźmicka J; Mazurowa A
Acta Haematol Pol; 1980; 11(1):25-30. PubMed ID: 6966114
[No Abstract] [Full Text] [Related]
31. [Prognostic relevancy of histomorphological bone marrow findings in chronic lymphocytic leukemia (CLL)].
Wutke K; Scheibner K
Folia Haematol Int Mag Klin Morphol Blutforsch; 1983; 110(2):218-30. PubMed ID: 6194055
[TBL] [Abstract][Full Text] [Related]
32. International prognostic index (IPI)--a critical comparison with five multiple myeloma staging systems in the group of 270 patients treated by conventional chemotherapy.
Scudla V; Zemanova M; Minarik J; Bacovsky J; Ordeltova M; Indrak K; Budikova M; Dusek L; Farbiakova V
Neoplasma; 2006; 53(4):277-84. PubMed ID: 16830053
[TBL] [Abstract][Full Text] [Related]
33. Bone marrow biopsy in chronic lymphocytic leukaemia: a study of 208 cases.
Montserrat E; Rozman C
Haematologia (Budap); 1983; 16(1-4):73-9. PubMed ID: 6679490
[TBL] [Abstract][Full Text] [Related]
34. Migration inhibition factor activity in sera of patients with chronic lymphatic leukemia.
Benjamin D; Aderka D; Livni E; Joshua H; Shaklai M; Pinkhas J
J Natl Cancer Inst; 1979 Nov; 63(5):1175-7. PubMed ID: 388014
[TBL] [Abstract][Full Text] [Related]
35. Chronic lymphocytic leukemia: staging and prognostic factors.
Zwiebel JA; Cheson BD
Semin Oncol; 1998 Feb; 25(1):42-59. PubMed ID: 9482526
[TBL] [Abstract][Full Text] [Related]
36. Lymphocyte doubling time in chronic lymphocytic leukemia modern era: a real-life study in 848 unselected patients.
Baumann T; Moia R; Gaidano G; Delgado J; Condoluci A; Villamor N; Payedimarri AB; Costa D; Patriarca A; Jiménez-Vicente C; Rossi D; Montserrat E
Leukemia; 2021 Aug; 35(8):2325-2331. PubMed ID: 33542480
[TBL] [Abstract][Full Text] [Related]
37. 'Prolymphocytoid' cells in chronic lymphocytic leukaemia and their prognostic significance.
Economopoulos T; Fotopoulos S; Hatzioannou J; Gardikas C
Scand J Haematol; 1982 Mar; 28(3):238-42. PubMed ID: 7089483
[TBL] [Abstract][Full Text] [Related]
38. A clinical staging system for chronic lymphocytic leukemia: prognostic significance.
Binet JL; Leporrier M; Dighiero G; Charron D; D'Athis P; Vaugier G; Beral HM; Natali JC; Raphael M; Nizet B; Follezou JY
Cancer; 1977 Aug; 40(2):855-64. PubMed ID: 890666
[No Abstract] [Full Text] [Related]
39. [Prognosis of chronic lymphatic leukemia].
Heilmann E; Schreck B
Haematologia (Budap); 1978-1979; 12(1-4):231-45. PubMed ID: 757537
[TBL] [Abstract][Full Text] [Related]
40. Relationship of clinical staging and lymphocyte morphology to survival in chronic lymphocytic leukaemia.
Peterson LC; Bloomfield CD; Brunning RD
Br J Haematol; 1980 Apr; 44(4):563-7. PubMed ID: 7378316
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
